...
首页> 外文期刊>ACS Omega >Design and Characterization of Cyclosporine A-Loaded Nanofibers for Enhanced Drug Dissolution
【24h】

Design and Characterization of Cyclosporine A-Loaded Nanofibers for Enhanced Drug Dissolution

机译:增强药物溶解度的环孢素A纳米纤维的设计与表征

获取原文
           

摘要

Despite widespread use as an immunosuppressant, the therapeutic efficacy of the undecapeptide cyclosporine A (CyA) is compromised when given by the oral route because of the innate hydrophobicity of the drug molecule, potentially leading to poor aqueous solubility and bioavailability. The aim of this study was to develop and characterize nanofibers based on the water-miscible polymer polyvinylpyrrolidone (PVP), incorporating CyA preloaded into polymeric surfactants so as to promote micelle formation on hydration; therefore, this approach represents the novel combination of three dissolution enhancement methodologies, namely solid dispersion technology, micellar systems, and nanofibers with enhanced surface area. The preparation of the nanofibers was performed in two steps. First, mixed micelles composed of the water-soluble vitamin E derivative d-α-tocopheryl poly(ethylene glycol) 1000 succinate and the amphiphilic triblock polymer Pluronic F127 (Poloxamer 407) were prepared. The micelles were characterized in terms of size, surface charge, drug loading, and encapsulation efficiency using transmission electron microscopy, dynamic light scattering, Fourier-transform infrared spectroscopy, high-performance liquid chromatography, and scanning electron and atomic force microscopy analysis. Nanofibers composed of PVP and the drug-loaded surfactant system were then prepared via electrospinning, with accompanying thermal, spectroscopic, and surface topological analysis. Dissolution studies indicated an extremely rapid dissolution profile for the fibers compared to the drug alone, while wettability studies also indicated a marked decrease in contact angle compared to the drug alone. Overall, the new approach appears to offer a viable means for considerably improving the dissolution of the hydrophobic peptide CyA, with associated implications for improved oral bioavailability.
机译:尽管广泛用作免疫抑制剂,但是由于药物分子的固有疏水性,当通过口服途径给予时,十一肽环孢菌素A(CyA)的治疗功效受到损害,这可能导致不良的水溶性和生物利用度。这项研究的目的是开发和表征基于水溶性聚合物聚乙烯吡咯烷酮(PVP)的纳米纤维,将预加载的CyA掺入聚合物表面活性剂中,从而促进水合时胶束的形成。因此,该方法代表了三种溶出度提高方法的新颖组合,即固体分散技术,胶束体系和表面积增大的纳米纤维。纳米纤维的制备分两个步骤进行。首先,制备由水溶性维生素E衍生物d-α-生育酚基聚(乙二醇)1000琥珀酸酯和两亲性三嵌段聚合物Pluronic F127(Poloxamer 407)组成的混合胶束。使用透射电子显微镜,动态光散射,傅立叶变换红外光谱,高效液相色谱以及扫描电子和原子力显微镜分析对胶束的尺寸,表面电荷,载药量和包封效率进行表征。然后,通过静电纺丝,伴随的热学,光谱学和表面拓扑分析,制备了由PVP和载有药物的表面活性剂系统组成的纳米纤维。溶出度研究表明,与单独使用药物相比,纤维的溶出曲线非常迅速,而润湿性研究还表明,与单独使用药物相比,接触角显着降低。总体而言,新方法似乎提供了一种可行的手段,可大大改善疏水肽CyA的溶解性,并具有改善口服生物利用度的相关含义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号